<DOC>
	<DOCNO>NCT00899145</DOCNO>
	<brief_summary>This research study look breast cancer risk woman BRCA1/BRCA2 mutation carrier . Studying sample DNA laboratory woman BRCA1/BRCA2 mutation carrier may help doctor identify biomarkers related cancer .</brief_summary>
	<brief_title>Breast Cancer Risk Women Who Are BRCA1/BRCA2 Mutation Carriers</brief_title>
	<detailed_description>OBJECTIVE : I . To identify potential genetic modifier breast cancer risk woman carrier breast cancer susceptibility gene , BRCA1/2 , collect data genetic information GOG-0199 contributing Consortium Investigators Modifiers BRCA-Associated Breast Cancer ( CIMBA ) , international consortium clinical cancer genetics investigator . OUTLINE : This multicenter study . Patients stratify study , country residence , ethnicity , birth cohort . Joint analysis BRCA1 BRCA2 mutation carrier stratify mutation . Previously collect DNA sample associate clinical information obtain BRCA mutation-positive participant enrol GOG-0199 study . DNA sample analyze mutation test variant ( i.e. , single nucleotide polymorphism [ SNPs ] ) candidate gene interest . Once genetic test give set variant complete , cod laboratory data file merge select demographic , clinical , epidemiological data obtain GOG-0199 baseline questionnaire submit Consortium Investigators Modifiers BRCA-Associated Breast Cancer ( CIMBA ) Central Database analyze publish data . The epidemiological SNP data contribute central database distribute investigator responsible analysis particular SNP set SNPs candidate gene genetic pathway .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Women without personal history breast cancer prior enrollment Gynecologic Oncology Group ( GOG ) 0199 Known currently BRCA1/2 mutation carrier either confirm outside report research test No BRCA1/2 mutationnegative mutationunknown status Enrolled clinical trial GOG0199 AND meet follow criterion : Completed baseline questionnaire ( BQ199 ) Provided information previous breast cancer history , include date diagnosis Provided complete data DNA analysis genetic variant interest Available DNA sample analysis Hormone receptor status specify Pre postmenopausal status</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>